Literature DB >> 7989095

Viral hepatitis and hepatocellular carcinoma.

R Sallie1, A M Di Bisceglie.   

Abstract

Hepatocellular carcinoma (HCC) is one of the more common internal malignancies worldwide and is responsible for over 1 million deaths annually. The causative relationship between chronic hepatitis B and HCC is now beyond doubt, and it is likely that the attributable risk of HCC due to hepatitis C virus (HCV) infection is similar to or greater than that for hepatitis B in some countries. The prospects for preventing HCC with the use of a vaccine against HBV appear excellent. Until a vaccine against HCV becomes available, prevention of HCV-related HCC is predominantly dependent on a reduction in transfusion-associated disease.

Entities:  

Mesh:

Year:  1994        PMID: 7989095

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  15 in total

Review 1.  Current perspectives in cancer proteomics.

Authors:  Miriam V Dwek; Sarah L Rawlings
Journal:  Mol Biotechnol       Date:  2002-10       Impact factor: 2.695

Review 2.  Hepatitis B virus, the vaccine, and the control of primary cancer of the liver.

Authors:  B S Blumberg
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 3.  Heme oxygenase-1 as a therapeutic target in inflammatory disorders of the gastrointestinal tract.

Authors:  Vijith Vijayan; Sebastian Mueller; Eveline Baumgart-Vogt; Stephan Immenschuh
Journal:  World J Gastroenterol       Date:  2010-07-07       Impact factor: 5.742

4.  Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients.

Authors:  Gautam Mondal; Urmimala Chatterjee; Yogesh K Chawla; Bishnu Pada Chatterjee
Journal:  Glycoconj J       Date:  2010-12-14       Impact factor: 2.916

5.  Total serum glycan analysis is superior to lectin-FLISA for the early detection of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Nikhil Anbarasan; Lucy Betesh; Aykan Karabudak; Ethan Moritz; Karthik Devarajan; Jorge Marrero; Timothy M Block; Anand Mehta
Journal:  Proteomics Clin Appl       Date:  2013-09-13       Impact factor: 3.494

6.  Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Mengjun Wang; Lucy Rodemich-Betesh; Julie Hafner; Anne Lamontagne; Andrew Klein; Jorge Marrero; Adrian M Di Bisceglie; Robert Gish; Timothy Block; Anand Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-05       Impact factor: 4.254

7.  Risk factors for hepatocellular carcinoma in patients with cirrhosis.

Authors:  Steedman A Sarbah; Terry Gramlich; Abraham Younoszai; Pat Osmack; Marlene Goormastic; Leonard Grosso; James N Cooper; Adrian Di Bisceglie; Russell Seneca; Zobair M Younossi
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Linkage specific fucosylation of alpha-1-antitrypsin in liver cirrhosis and cancer patients: implications for a biomarker of hepatocellular carcinoma.

Authors:  Mary Ann Comunale; Lucy Rodemich-Betesh; Julie Hafner; Mengjun Wang; Pamela Norton; Adrian M Di Bisceglie; Timothy Block; Anand Mehta
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

9.  Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.

Authors:  Mengjun Wang; Ronald E Long; Mary Ann Comunale; Omer Junaidi; Jorge Marrero; Adrian M Di Bisceglie; Timothy M Block; Anand S Mehta
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05-19       Impact factor: 4.254

10.  Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.

Authors:  Gautam Mondal; Ashish Saroha; Partha Pratim Bose; B P Chatterjee
Journal:  Glycoconj J       Date:  2016-03-31       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.